Cassava Sciences Analyst Ratings
Cassava Sciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/08/2023 | 554.35% | HC Wainwright & Co. | → $124 | Reiterates | Buy → Buy |
| 07/06/2023 | 554.35% | HC Wainwright & Co. | $124 → $124 | Reiterates | Buy → Buy |
| 05/11/2023 | 554.35% | HC Wainwright & Co. | → $124 | Reiterates | Buy → Buy |
| 05/09/2023 | 554.35% | HC Wainwright & Co. | → $124 | Reiterates | → Buy |
| 03/06/2023 | 554.35% | HC Wainwright & Co. | → $124 | Reiterates | → Buy |
| 01/24/2023 | 554.35% | HC Wainwright & Co. | → $124 | Reiterates | → Buy |
| 08/11/2022 | 132.19% | B. Riley Securities | $58 → $44 | Maintains | Buy |
| 01/24/2022 | 279.95% | B. Riley Securities | $108 → $72 | Maintains | Buy |
| 07/20/2021 | 554.35% | HC Wainwright & Co. | $97 → $124 | Maintains | Buy |
| 06/23/2021 | 485.75% | B. Riley Securities | $78 → $111 | Maintains | Buy |
| 04/27/2021 | 311.61% | B. Riley Securities | → $78 | Initiates Coverage On | → Buy |
| 03/17/2021 | 480.47% | JonesTrading | → $110 | Initiates Coverage On | → Buy |
| 02/23/2021 | 411.87% | HC Wainwright & Co. | $66 → $97 | Maintains | Buy |
| 02/16/2021 | 322.16% | Maxim Group | $14 → $80 | Maintains | Buy |
| 02/16/2021 | 248.28% | HC Wainwright & Co. | $20 → $66 | Maintains | Buy |
| 10/23/2020 | 26.65% | Cantor Fitzgerald | → $24 | Initiates Coverage On | → Overweight |
| 09/23/2020 | 5.54% | HC Wainwright & Co. | → $20 | Upgrades | Neutral → Buy |
| 09/14/2020 | -26.12% | Maxim Group | → $14 | Upgrades | Hold → Buy |
| 05/18/2020 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 05/08/2020 | -15.57% | HC Wainwright & Co. | $6 → $16 | Reiterates | → Buy |
| 12/06/2019 | -68.34% | HC Wainwright & Co. | $3 → $6 | Reiterates | → Buy |
| 08/01/2019 | -84.17% | HC Wainwright & Co. | → $3 | Initiates Coverage On | → Buy |
| 06/25/2019 | -84.17% | Maxim Group | → $3 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/08/2023 | 554.35% | HC Wainwright & Co. | → 124 美元 | 重申 | 購買 → 購買 |
| 07/06/2023 | 554.35% | HC Wainwright & Co. | 124 美元 → 124 美元 | 重申 | 購買 → 購買 |
| 05/11/2023 | 554.35% | HC Wainwright & Co. | → 124 美元 | 重申 | 購買 → 購買 |
| 05/09/2023 | 554.35% | HC Wainwright & Co. | → 124 美元 | 重申 | → 購買 |
| 03/06/2023 | 554.35% | HC Wainwright & Co. | → 124 美元 | 重申 | → 購買 |
| 01/24/2023 | 554.35% | HC Wainwright & Co. | → 124 美元 | 重申 | → 購買 |
| 08/11/2022 | 132.19% | B. 萊利證券 | 58 美元 → 44 美元 | 維護 | 購買 |
| 2022 年 1 月 24 日 | 279.95% | B. 萊利證券 | 108 美元 → 72 美元 | 維護 | 購買 |
| 2021 年 7 月 20 日 | 554.35% | HC Wainwright & Co. | 97 美元 → 124 美元 | 維護 | 購買 |
| 06/23/2021 | 485.75% | B. 萊利證券 | 78 美元 → 111 美元 | 維護 | 購買 |
| 04/27/2021 | 311.61% | B. 萊利證券 | → 78 美元 | 啓動覆蓋開啓 | → 購買 |
| 2021 年 3 月 17 日 | 480.47% | JonesTrading | → 110 美元 | 啓動覆蓋開啓 | → 購買 |
| 2021 年 2 月 23 日 | 411.87% | HC Wainwright & Co. | 66 美元 → 97 美元 | 維護 | 購買 |
| 2021 年 2 月 16 日 | 322.16% | Maxim 集團 | 14 美元 → 80 美元 | 維護 | 購買 |
| 2021 年 2 月 16 日 | 248.28% | HC Wainwright & Co. | 20 美元 → 66 美元 | 維護 | 購買 |
| 2020 年 10 月 23 日 | 26.65% | 坎託·菲茨傑拉德 | → 24 美元 | 啓動覆蓋開啓 | → 超重 |
| 2020 年 9 月 23 日 | 5.54% | HC Wainwright & Co. | → 20 美元 | 升級 | 中性 → 買入 |
| 2020 年 9 月 14 日 | -26.12% | Maxim 集團 | → 14 美元 | 升級 | 持有 → 買入 |
| 2020 年 5 月 18 日 | — | HC Wainwright & Co. | 降級 | 買入 → 中性 | |
| 05/08/2020 | -15.57% | HC Wainwright & Co. | 6 美元 → 16 美元 | 重申 | → 購買 |
| 2019 年 6 月 12 日 | -68.34% | HC Wainwright & Co. | 3 美元 → 6 美元 | 重申 | → 購買 |
| 08/01/2019 | -84.17% | HC Wainwright & Co. | → 3 美元 | 啓動覆蓋開啓 | → 購買 |
| 06/25/2019 | -84.17% | Maxim 集團 | → 3 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Cassava Sciences (SAVA)?
木薯科學（SAVA）的目標價格是多少？
The latest price target for Cassava Sciences (NASDAQ: SAVA) was reported by HC Wainwright & Co. on August 8, 2023. The analyst firm set a price target for $124.00 expecting SAVA to rise to within 12 months (a possible 554.35% upside). 7 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月8日公佈了木薯科學（納斯達克股票代碼：SAVA）的最新目標股價。這家分析公司將目標股價定爲124.00美元，預計SAVA將在12個月內升至12個月內（可能上漲554.35％）。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Cassava Sciences (SAVA)?
分析師對木薯科學（SAVA）的最新評級是多少？
The latest analyst rating for Cassava Sciences (NASDAQ: SAVA) was provided by HC Wainwright & Co., and Cassava Sciences reiterated their buy rating.
Cassava Sciences（納斯達克股票代碼：SAVA）的最新分析師評級由HC Wainwright & Co. 提供，Cassava Sciences重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Cassava Sciences (SAVA)?
Cassava Sciences（SAVA）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cassava Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cassava Sciences was filed on August 8, 2023 so you should expect the next rating to be made available sometime around August 8, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Cassava Sciences的高管和客戶交談以及聽取業績電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Cassava Sciences的最後一次評級是在2023年8月8日提交的，因此你應該預計下一個評級將在2024年8月8日左右公佈。
Is the Analyst Rating Cassava Sciences (SAVA) correct?
分析師對木薯科學 (SAVA) 的評級是否正確？
While ratings are subjective and will change, the latest Cassava Sciences (SAVA) rating was a reiterated with a price target of $0.00 to $124.00. The current price Cassava Sciences (SAVA) is trading at is $18.95, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的木薯科學（SAVA）評級得到重申，目標股價爲0.00美元至124.00美元。Cassava Sciences（SAVA）目前的交易價格爲18.95美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。